Arcoma AB (STO:ARCOMA)
Sweden · Delayed Price · Currency is SEK 9.98
+0.12 (1.22%)
Jul 17, 2025, 10:59 AM CET
Arcoma AB Revenue
Arcoma AB had revenue of 34.88M SEK in the quarter ending March 31, 2025, a decrease of -24.94%. This brings the company's revenue in the last twelve months to 145.22M, down -15.52% year-over-year. In the year 2024, Arcoma AB had annual revenue of 156.81M, down -3.81%.
Revenue (ttm)
145.22M
Revenue Growth
-15.52%
P/S Ratio
0.97
Revenue / Employee
4.84M
Employees
31
Market Cap
141.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 156.81M | -6.21M | -3.81% |
| Dec 31, 2023 | 163.02M | 37.97M | 30.36% |
| Dec 31, 2022 | 125.05M | 7.92M | 6.76% |
| Dec 31, 2021 | 117.13M | -287.00K | -0.24% |
| Dec 31, 2020 | 117.42M | -16.26M | -12.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| Asker Healthcare Group AB | 15.57B |
| Vimian Group AB | 4.24B |
| AddLife AB | 10.44B |